Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Angiotensin Receptor Blockers (ARBs) Global Market Report 2025
Request Sample Buy Now
Global Angiotensin Receptor Blockers (ARBs) Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Angiotensin Receptor Blockers (ARBs) Global Market Report 2025

By Product (Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan), By Application (Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers ) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Angiotensin Receptor Blockers (ARBs) Market Overview

• Angiotensin Receptor Blockers (ARBs) market size has reached to $8.51 billion in 2024

• Expected to grow to $10.52 billion in 2029 at a compound annual growth rate (CAGR) of 4.6%

• Growth Driver: Rising Cardiovascular Disease Incidence Sparks Surge In Angiotensin Receptor Blockers Market

• Market Trend: Innovative Product Solution In The Angiotensin Receptor Blockers Market

• North America was the largest region in 2024.

What Is Covered Under Angiotensin Receptor Blockers (ARBs) Market?

Angiotensin receptor blockers (ARBs) are medications that dilate (widen) blood vessels and are used to treat conditions such as high blood pressure (hypertension), heart failure, and kidney disease in people with diabetes. Angiotensin is a chemical in the body that causes blood vessels to constrict. This constriction can raise the blood pressure and make the heart work harder.

The main products of angiotensin receptor blockers (ARBs) include valsartan, losartan, irbesartan, azilsartan and olmesartan. Losartan is an angiotensin receptor blocker that lowers the risk of stroke while treating hypertension and diabetic nephropathy. Their various applications include hypertension, cardiovascular diseases, kidney diseases, and others for use by end-users such as hospitals, specialty clinics, and ambulatory surgical centers.

Angiotensin Receptor Blockers (ARBs) Global Market Report 2025 Market Size and growth rate 2025 to 2029: Graph

What Is The Angiotensin Receptor Blockers (ARBs) Market Size 2025 And Growth Rate?

The angiotensin receptor blockers (ARBs) market size has grown steadily in recent years. It will grow from $8.51 billion in 2024 to $8.78 billion in 2025 at a compound annual growth rate (CAGR) of 3.1%. The growth in the historic period can be attributed to hypertension epidemic, clinical efficacy, cardiovascular disease burden, renal protection, clinical guidelines, ARBs as first-line treatment, cost-effectiveness.

What Is The Angiotensin Receptor Blockers (ARBs) Market Growth Forecast?

The angiotensin receptor blockers (ARBs) market size is expected to see steady growth in the next few years. It will grow to $10.52 billion in 2029 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to precision medicine approaches, focus on combination therapies, global expansion of market, biomarker-based treatment strategies, government initiatives, increased awareness of hypertension. Major trends in the forecast period include telemedicine adoption, research and development investments, generic competition and patent expirations, digital health solutions for medication adherence, biosimilar competition.

The forecast of 4.6% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. primary care practices by increasing the cost of angiotensin II receptor blockers such as losartan and valsartan sourced from India and Israel, thereby limiting hypertension treatment options and elevating cardiovascular medication expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Angiotensin Receptor Blockers (ARBs) Market Segmented?

1) By Product: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan

2) By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications

3) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers

Subsegments:

1) By Valsartan: Tablets, Capsules, Injectable Forms

2) By Telmisartan: Tablets, Capsules

3) By Losartan: Tablets, Oral Solution

4) By Irbesartan: Tablets, Oral Solution

5) By Azilsartan: Tablets

6) By Olmesartan: Tablets, Oral Suspension

What Is Driving The Angiotensin Receptor Blockers (ARBs) Market? Rising Cardiovascular Disease Incidence Sparks Surge In Angiotensin Receptor Blockers Market

The increasing incidence of cardiovascular diseases is expected to propel the growth of the angiotensin receptor blockers market going forward. Cardiovascular disease (CVD) is any condition affecting the heart or blood vessels. It is frequently associated with the development of fatty deposits within the arteries (atherosclerosis) and an increased risk of blood clots. Angiotensin receptor blockers lower blood pressure and improve the heart's capacity to pump blood by helping in vein and artery relaxation, which can minimize the risk of cardiovascular disease. For instance, in August 2022, according to the American College of Cardiology, a US-based professional medical organization, the expected rates of cardiovascular risk factors and disease will considerably rise in the United States by the year 2060. Therefore, the increasing incidence of cardiovascular diseases is driving the growth of the angiotensin receptor blockers market.

What Is Driving The Angiotensin Receptor Blockers (ARBs) Market? Rising Chronic Kidney Disease Rates Drive Surge In Angiotensin Receptor Blockers Market

The increasing chronic kidney diseases is expected to propel the growth of the angiotensin receptor blockers market going forward. Chronic kidney disease (CKD) is a long-term condition characterized by the gradual loss of kidney function over time. Angiotensin receptor blockers (ARBs) are used in the management of chronic kidney diseases (CKD) by lowering blood pressure, provide renal protection, to manage diabetic nephropathy, and in cardiovascular complications. For instance, in June 2023, according to the University of Oxford, a UK-based higher education institution, from 2022 to 2032, the prevalence of CKD is expected to increase by 4% from 8.27 million to 8.61 million people in the UK. Therefore, the increasing chronic kidney diseases are driving the growth of the angiotensin receptor blockers market.

What Is Driving The Angiotensin Receptor Blockers (ARBs) Market? Rising Hypertension Rates Propel Growth In Angiotensin Receptor Blockers (ARBs) Market

The increase in the prevalence of hypertension diseases is expected to propel the growth of the angiotensin receptor blockers (ARBs) market going forward. Hypertension, often known as high or rising blood pressure, is a disorder characterized by chronically elevated blood vessel pressure. Angiotensin receptor blockers (ARBs) are a type of medication that is commonly used to treat hypertension. They primarily function by relaxing and widening the blood arteries, giving the blood greater room to pass through. Thus, increasing hypertension diseases among people will increase the demand for angiotensin receptor blockers. For instance, in March 2023, the World Health Organization, a Switzerland-based intergovernmental organization published that approximately 1.28 billion adults aged 30 to 79 globally have hypertension, with the majority (two-thirds) residing in low- and middle-income countries. It is estimated that 46% of adults with hypertension are unaware of their condition. Also, in December 2023, according to The Australian Bureau of Statistics, an Australia-based government agency published that in 2022, more than one in ten individuals (11.6% or 3.0 million) reported having hypertension. Therefore, the increase in the prevalence of hypertension diseases is driving the growth of the angiotensin receptor blockers (ARBs) industry.

Who Are The Major Players In The Global Angiotensin Receptor Blockers (ARBs) Market?

Major companies operating in the angiotensin receptor blockers (ARBs) market include Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca Plc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Lupin Limited, Dr. Reddy’s Laboratories Ltd., Takeda Pharmaceutical Company Limited, Thermo Fisher Scientific, Sanofi, Johnson & Johnson, Eli Lilly, Bayer AG, Abbvie Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Zydus Cadila, Glenmark Pharmaceuticals Ltd., Cipla Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zhejiang Huahai Pharmaceutical Co. Ltd., Boehringer Ingelheim Ltd., Astellas Pharma

What Are The Key Trends Of The Global Angiotensin Receptor Blockers (ARBs) Market? Innovative Product Solution In The Angiotensin Receptor Blockers Market

Major companies in the angiotensin receptor blocker market are developing advanced products, such as angiotensin receptor neprilysin inhibitors, to enhance treatment options and improve outcomes for patients with cardiovascular conditions. Angiotensin receptor neprilysin inhibitors (ARNIs) are a class of medications used to treat heart failure. For instance, In January 2023, Glenmark Pharmaceuticals, an India-based pharmaceutical company, launched sacubitril + valsartan tablets, which specialize in the treatment of heart failure, specifically targeting heart failure with reduced ejection fraction (HFrEF). This combination falls under the class of medications known as ARNI (angiotensin receptor neprilysin inhibitors). Sacubitril enhances the natriuretic peptide (NP) system, which alleviates fluid overload and promotes blood vessel dilation, while valsartan blocks the renin-angiotensin system (RAS) to lower blood pressure and lessens the heart's workload. Together, they effectively improve heart failure symptoms, reduce the risk of cardiovascular mortality, and decrease the chances of hospitalization due to heart failure. They are marketed under the brand name Sacu V.

Global Angiotensin Receptor Blockers (ARBs) Market Trend: Advancements in Angiotensin Receptor Blockers (ARBs) for Hypertension Treatment

Major market players in the angiotensin receptor blockers (ARBs) market are developing advanced products, such as prescription medications, to enhance the treatment of conditions like hypertension and heart failure and improve patient outcomes. Prescription medication refers to drugs that are legally dispensed to patients only when prescribed by a licensed healthcare professional, such as a doctor, nurse practitioner, or dentist. For instance, in July 2022, Lupin, an India-based transnational pharmaceutical company received approval from the Food and Drug Administration (FDA), a US-based federal agency for protecting the public health of Azilsartan Medoxomil Tablets. Azilsartan Medoxomil Tablets is a prescription medication used primarily for the treatment of hypertension (high blood pressure). They provide an effective treatment option for hypertension, helping to lower blood pressure and reduce the risk of cardiovascular events. They belong to a class of drugs called angiotensin II receptor blockers (ARBs), which work by relaxing blood vessels, allowing blood to flow more easily, and thereby helping to lower blood pressure. Lowering blood pressure helps prevent strokes, heart attacks, and kidney problems.

Need data on a specific region in this market?
Request Customisation

Regional Analysis For The Global Angiotensin Receptor Blockers (ARBs) Market

North America was the largest region in the angiotensin receptor blockers (ARBs) market share in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Angiotensin Receptor Blockers (ARBs) Market?

The angiotensin receptor blockers (ARBs) market consists of sales of candesartan and eprosartan. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Angiotensin Receptor Blockers (ARBs) Industry?

The angiotensin receptor blockers (arbs) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the angiotensin receptor blockers (arbs) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Angiotensin Receptor Blockers (ARBs) Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $8.78 billion
Revenue Forecast In 2034 $10.52 billion
Growth Rate CAGR of 4.6% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Product: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan
2) By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications
3) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers Subsegments: 1) By Valsartan: Tablets, Capsules, Injectable Forms
2) By Telmisartan: Tablets, Capsules
3) By Losartan: Tablets, Oral Solution
4) By Irbesartan: Tablets, Oral Solution
5) By Azilsartan: Tablets 6) By Olmesartan: Tablets, Oral Suspension
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca Plc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Lupin Limited, Dr. Reddy’s Laboratories Ltd., Takeda Pharmaceutical Company Limited, Thermo Fisher Scientific, Sanofi, Johnson & Johnson, Eli Lilly, Bayer AG, Abbvie Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Zydus Cadila, Glenmark Pharmaceuticals Ltd., Cipla Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zhejiang Huahai Pharmaceutical Co. Ltd., Boehringer Ingelheim Ltd., Astellas Pharma
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Angiotensin Receptor Blockers (ARBs) Market Characteristics

3. Angiotensin Receptor Blockers (ARBs) Market Trends And Strategies

4. Angiotensin Receptor Blockers (ARBs) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Angiotensin Receptor Blockers (ARBs) Growth Analysis And Strategic Analysis Framework

5.1. Global Angiotensin Receptor Blockers (ARBs) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Angiotensin Receptor Blockers (ARBs) Market Growth Rate Analysis

5.4. Global Angiotensin Receptor Blockers (ARBs) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Angiotensin Receptor Blockers (ARBs) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Angiotensin Receptor Blockers (ARBs) Total Addressable Market (TAM)

6. Angiotensin Receptor Blockers (ARBs) Market Segmentation

6.1. Global Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Valsartan

Telmisartan

Losartan

Irbesartan

Azilsartan

Olmesartan

6.2. Global Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hypertension

Cardiovascular Diseases

Kidney Diseases

Other Applications

6.3. Global Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Specialty Clinics

Ambulatory Surgical Centers

6.4. Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Valsartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tablets

Capsules

Injectable Forms

6.5. Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Telmisartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tablets

Capsules

6.6. Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Losartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tablets

Oral Solution

6.7. Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Irbesartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tablets

Oral Solution

6.8. Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Azilsartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tablets

6.9. Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Olmesartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tablets

Oral Suspension

7. Angiotensin Receptor Blockers (ARBs) Market Regional And Country Analysis

7.1. Global Angiotensin Receptor Blockers (ARBs) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Angiotensin Receptor Blockers (ARBs) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Market

8.1. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Angiotensin Receptor Blockers (ARBs) Market

9.1. China Angiotensin Receptor Blockers (ARBs) Market Overview

9.2. China Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Angiotensin Receptor Blockers (ARBs) Market

10.1. India Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Angiotensin Receptor Blockers (ARBs) Market

11.1. Japan Angiotensin Receptor Blockers (ARBs) Market Overview

11.2. Japan Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Angiotensin Receptor Blockers (ARBs) Market

12.1. Australia Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Angiotensin Receptor Blockers (ARBs) Market

13.1. Indonesia Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Angiotensin Receptor Blockers (ARBs) Market

14.1. South Korea Angiotensin Receptor Blockers (ARBs) Market Overview

14.2. South Korea Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Angiotensin Receptor Blockers (ARBs) Market

15.1. Western Europe Angiotensin Receptor Blockers (ARBs) Market Overview

15.2. Western Europe Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Angiotensin Receptor Blockers (ARBs) Market

16.1. UK Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Angiotensin Receptor Blockers (ARBs) Market

17.1. Germany Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Angiotensin Receptor Blockers (ARBs) Market

18.1. France Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Angiotensin Receptor Blockers (ARBs) Market

19.1. Italy Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Angiotensin Receptor Blockers (ARBs) Market

20.1. Spain Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Angiotensin Receptor Blockers (ARBs) Market

21.1. Eastern Europe Angiotensin Receptor Blockers (ARBs) Market Overview

21.2. Eastern Europe Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Angiotensin Receptor Blockers (ARBs) Market

22.1. Russia Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Angiotensin Receptor Blockers (ARBs) Market

23.1. North America Angiotensin Receptor Blockers (ARBs) Market Overview

23.2. North America Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Angiotensin Receptor Blockers (ARBs) Market

24.1. USA Angiotensin Receptor Blockers (ARBs) Market Overview

24.2. USA Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Angiotensin Receptor Blockers (ARBs) Market

25.1. Canada Angiotensin Receptor Blockers (ARBs) Market Overview

25.2. Canada Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Angiotensin Receptor Blockers (ARBs) Market

26.1. South America Angiotensin Receptor Blockers (ARBs) Market Overview

26.2. South America Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Angiotensin Receptor Blockers (ARBs) Market

27.1. Brazil Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Angiotensin Receptor Blockers (ARBs) Market

28.1. Middle East Angiotensin Receptor Blockers (ARBs) Market Overview

28.2. Middle East Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Angiotensin Receptor Blockers (ARBs) Market

29.1. Africa Angiotensin Receptor Blockers (ARBs) Market Overview

29.2. Africa Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Angiotensin Receptor Blockers (ARBs) Market Competitive Landscape And Company Profiles

30.1. Angiotensin Receptor Blockers (ARBs) Market Competitive Landscape

30.2. Angiotensin Receptor Blockers (ARBs) Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. AstraZeneca Plc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Angiotensin Receptor Blockers (ARBs) Market Other Major And Innovative Companies

31.1. GlaxoSmithKline plc

31.2. Teva Pharmaceutical Industries Ltd.

31.3. Daiichi Sankyo Company Limited

31.4. Lupin Limited

31.5. Dr. Reddy’s Laboratories Ltd.

31.6. Takeda Pharmaceutical Company Limited

31.7. Thermo Fisher Scientific

31.8. Sanofi

31.9. Johnson & Johnson

31.10. Eli Lilly

31.11. Bayer AG

31.12. Abbvie Inc.

31.13. Mylan N.V.

31.14. Sun Pharmaceutical Industries Ltd.

31.15. Torrent Pharmaceuticals Ltd.

32. Global Angiotensin Receptor Blockers (ARBs) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Angiotensin Receptor Blockers (ARBs) Market

34. Recent Developments In The Angiotensin Receptor Blockers (ARBs) Market

35. Angiotensin Receptor Blockers (ARBs) Market High Potential Countries, Segments and Strategies

35.1 Angiotensin Receptor Blockers (ARBs) Market In 2029 - Countries Offering Most New Opportunities

35.2 Angiotensin Receptor Blockers (ARBs) Market In 2029 - Segments Offering Most New Opportunities

35.3 Angiotensin Receptor Blockers (ARBs) Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Valsartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Telmisartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Losartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Irbesartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Azilsartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Olmesartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Angiotensin Receptor Blockers (ARBs) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Angiotensin Receptor Blockers (ARBs) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Pfizer Inc. Financial Performance
  • Table 81: Novartis AG Financial Performance
  • Table 82: Merck & Co. Inc. Financial Performance
  • Table 83: AstraZeneca Plc. Financial Performance
  • Table 84: Bristol-Myers Squibb Company Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Valsartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Telmisartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Losartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Irbesartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Azilsartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Olmesartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Angiotensin Receptor Blockers (ARBs) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Angiotensin Receptor Blockers (ARBs) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Pfizer Inc. Financial Performance
  • Figure 81: Novartis AG Financial Performance
  • Figure 82: Merck & Co. Inc. Financial Performance
  • Figure 83: AstraZeneca Plc. Financial Performance
  • Figure 84: Bristol-Myers Squibb Company Financial Performance

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Read More About A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Cardiovascular Drugs Global Market Report 2022 – By Type (Anti-Hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Dru...

View Report

Disposable Cutlery Global Market Report 2025 - By Type (Spoon, Fork, Knife), By Material (Plastic, Wood), By Sales Channel (Supermarkets, Hypermarkets, Convenience Stores, Specialty Stores, Discount Stores, E-Retail), By...

View Report

Osteoporosis Treatment Global Market Report 2025 – By Drug Type (Bisphosphonates, Calcitonin, Hormone Therapy, Selective Estrogen Receptor Modulators (SERMs), Parathyroid Hormone-Related Protein (PTHrP) Analog, Rank Liga...

View Report

Air Coolers Global Market Report 2025 – By Type (Tower, Desert, Other Types), By Size (Spot Cooler, Medium Space Cooler, Large Space Cooler), By Application (Industrial, Residential, Commercial) – Impact of Tariff and Tr...

View Report

Anti-Hypertensive Drugs Global Market Report 2025 – By Therapeutics (Diuretics, Angiotensin Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Beta Blockers, Alpha Blockers, Calcium Channel Blocker...

View Report

French Fries Global Market Report 2025 – By Product (Fresh, Frozen), By Distribution Channel (Supermarkets and Hypermarkets, Convenience Stores, Online, Distributors, Direct Purchase), By End-Use (Food Service, Retail) –...

View Report

Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2025 – By Product Type (Cardiopulmonary Stress Testing Systems, ECG Data Management Systems, ECG Monitoring Equipment, ECG Stress Testin...

View Report

Smart Ticketing Global Market Report 2025 – By Product (Ticket Machine, E-Ticket, E-Kiosk, Request Tracker), By Component (Hardware, Software), By System (Open Payment System, Smart Card, Near-Field Communication), By Or...

View Report

Frequently Asked Questions

Angiotensin receptor blockers (ARBs) are medications that dilate (widen) blood vessels and are used to treat conditions such as high blood pressure (hypertension), heart failure, and kidney disease in people with diabetes. Angiotensin is a chemical in the body that causes blood vessels to constrict. This constriction can raise the blood pressure and make the heart work harder. For further insights on this market, request a sample here

The market major growth driver - Rising Cardiovascular Disease Incidence Sparks Surge In Angiotensin Receptor Blockers Market. For further insights on this market, request a sample here

The angiotensin receptor blockers (arbs) market size has grown steadily in recent years. It will grow from $8.51 billion in 2024 to $8.78 billion in 2025 at a compound annual growth rate (CAGR) of 3.1%. The growth in the historic period can be attributed to hypertension epidemic, clinical efficacy, cardiovascular disease burden, renal protection, clinical guidelines, ARBs as first-line treatment, cost-effectiveness. The angiotensin receptor blockers (arbs) market size is expected to see steady growth in the next few years. It will grow to " $10.52 billion in 2029 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to precision medicine approaches, focus on combination therapies, global expansion of market, biomarker-based treatment strategies, government initiatives, increased awareness of hypertension. Major trends in the forecast period include telemedicine adoption, research and development investments, generic competition and patent expirations, digital health solutions for medication adherence, biosimilar competition. For further insights on this market, request a sample here

The angiotensin receptor blockers (arbs) market covered in this report is segmented –
1) By Product: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan
2) By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications
3) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers Subsegments:
1) By Valsartan: Tablets, Capsules, Injectable Forms
2) By Telmisartan: Tablets, Capsules
3) By Losartan: Tablets, Oral Solution
4) By Irbesartan: Tablets, Oral Solution
5) By Azilsartan: Tablets
6) By Olmesartan: Tablets, Oral Suspension For further insights on this market, request a sample here

North America was the largest region in the angiotensin receptor blockers (ARBs) market share in 2024. The regions covered in the angiotensin receptor blockers (ARBs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the angiotensin receptor blockers (ARBs) market include Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca Plc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Lupin Limited, Dr. Reddy’s Laboratories Ltd., Takeda Pharmaceutical Company Limited, Thermo Fisher Scientific, Sanofi, Johnson & Johnson, Eli Lilly, Bayer AG, Abbvie Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Zydus Cadila, Glenmark Pharmaceuticals Ltd., Cipla Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zhejiang Huahai Pharmaceutical Co. Ltd., Boehringer Ingelheim Ltd., Astellas Pharma . For further insights on this market, request a sample here.

Major trends in this market include Innovative Product Solution In The Angiotensin Receptor Blockers Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Angiotensin Receptor Blockers (ARBs) Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon